Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome

Robert L. Gustofson, James H. Segars, Frederick W. Larsen

Research output: Contribution to journalArticle

Abstract

Background: Elevated estradiol (E 2) levels predispose to development of ovarian hyperstimulation syndrome (OHSS). Since GnRH antagonist is associated with a reduction in E 2 levels, we hypothesized that GnRH-antagonist treatment of women down-regulated with GnRH agonist who are at risk of OHSS might reduce E 2 levels and avoid cycle cancellation. Methods: Retrospective study in a university-based assist ed reproduction technology (ART) programme in 87 patients treated with long luteal (LL) or microdose flare (MDF) with ovarian hyperresponse and 87 control patients without ovarian hyperresponse. GnRH-antagonist (ganirelix acetate) treatment was started and leuprolide acetate discontinued in women who failed to respond to a reduction in gonadotrophin dosage. Results: In the treatment group, there was a sign ificant, reproducible reduction in serum E 2 levels. Mean E 2 at the start of ganirelix treatment was 4219.8 pg/ml and decreased in 24 h to 2613.7 pg/ml (36.7%; P < 0.001). An average of 24.9 ± 8.8 oocytes were obtained at retrieval and an average of 19.1 ± 8.0 were metaphase II (79.2%). Fertilization occurred in 13.9 ± 8.1 embryos (72.8%). In this high risk group, two cases of severe OHSS (2.3%) occurred. The ongoing pregnancy rate was 51.8%. Compared with the control group, there were no statistically significant differences in the rate of oocyte recovery, oocyte maturity, 2PN rate, fertilization, cancellation, OHSS or pregnancy. Conclusions: GnRH-antagonist treatment of women pretreated w ith GnRH agonist rapidly reduced circulating serum E 2 without adversely affecting oocyte maturation, fertilization rates or embryo quality and resulted in a high pregnancy rate in this subgroup of patients at risk of OHSS.

Original languageEnglish (US)
Pages (from-to)2830-2837
Number of pages8
JournalHuman Reproduction
Volume21
Issue number11
DOIs
StatePublished - Nov 2006

    Fingerprint

Keywords

  • Cycle cancellation
  • Estradiol
  • Ganirelix acetate
  • GnRH agonist and antagonist
  • OHSS

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this